| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1021868-92-7 | ZM 39923 HCl |
≥98% | | 询价 |
| 2 | 1206101-20-3 | GLPG0634 analogue |
≥98% | | 询价 |
| 3 | 136194-77-9 | Go6976(PD40697) |
≥98% | | 询价 |
| 4 | 5108-96-3 | Pyrrolidinedithiocarbamate ammonium(PDTC) |
| 50mg, 100mg, 200mg | 询价 |
| 5 | 1206161-97-8 | Filgotinib(GLPG-0634) |
≥98% | | 询价 |
| 6 | 1369761-01-2 | Cerdulatinib HCl salt |
≥98% | | 询价 |
| 7 | 1226895-15-3 | FLLL32 |
≥98% | | 询价 |
| 8 | 1056634-68-4 | Momelotinib(LM1149 CYT387 CYT11387) |
≥98% | | 询价 |
| 9 | 133550-30-8 | AG-490(Tyrphostin B42 zinc0255794) |
≥98% | | 询价 |
| 10 | 944118-01-8 | Peficitinib(ASP-015K,JNJ-54781532) |
≥98% | | 询价 |
| 11 | 944842-54-0 | Decernotinib(VX-509 VRT-831509 adelatinib) |
≥98% | | 询价 |
| 12 | 1271022-90-2 | BMS-911543 |
≥98% | | 询价 |
| 13 | 896466-04-9 | AT9283 |
≥98% | | 询价 |
| 14 | 936091-26-8 | Fedratinib(SAR302503) |
≥98% | | 询价 |
| 15 | 935666-88-9 | AZD1480 |
≥98% | | 询价 |
| 16 | 540737-29-9 | Tofacitinib(CP690550)Citrate |
≥98% | | 询价 |
| 17 | 941678-49-5 | Ruxolitinib(INCB-018424 INC-424) |
≥98% | | 询价 |
| 18 | 927822-86-4 | KC7F2 |
≥98% | | 询价 |
| 19 | 223387-75-5 | FG-2216 |
≥98% | | 询价 |
| 20 | 685898-44-6 | PX-478 2HCl |
≥98% | | 询价 |
| 21 | 1227158-85-1 | BAY 87-2243 |
≥98% | | 询价 |
| 22 | 931398-72-0 | IOX2 |
≥98% | | 询价 |
| 23 | 1797989-42-4 | CHIR-99021(CT99021)HCl |
≥98% | | 询价 |
| 24 | 552325-73-2 | A-674563 |
≥98% | | 询价 |
| 25 | 885499-61-6 | CCT128930 |
≥98% | | 询价 |
| 26 | 35943-35-2 | Triciribine |
≥98% | | 询价 |
| 27 | 391210-10-9 | Mirdametinib(PD0325901) |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 28 | 857531-00-1 | AT7867 |
≥98% | | 询价 |
| 29 | 28718-90-3 | DAPI Dihydrochloride |
| 5mg, 10mg, 25mg, 50mg | 询价 |
| 30 | 1001264-89-6 | Ipatasertib(GDC0068 RG7440) |
≥98% | | 询价 |
| 31 | 937174-76-0 | GSK-690693 |
≥98% | | 询价 |
| 32 | 157716-52-4 | Perifosine(KRX0401) |
≥98% | | 询价 |
| 33 | 1032350-13-2 | MK-2206 2HCl |
≥98% | | 询价 |
| 34 | 1608125-21-8 | AMG319(ACP-319) |
≥98% | | 询价 |
| 35 | 1627494-13-6 | AZD8186 |
≥98% | | 询价 |
| 36 | 1276553-09-3 | PF-4989216 |
≥98% | | 询价 |
| 37 | 934526-89-3 | Pilaralisib(XL147) |
≥98% | | 询价 |
| 38 | 955977-50-1 | PI-3065 |
≥98% | | 询价 |
| 39 | 1276110-06-5 | HS-173 |
≥98% | | 询价 |
| 40 | 117-39-5 | Quercetin(Sophoretin NSC 9221 Kvercetin) |
≥98% | | 询价 |
| 41 | 1394076-92-6 | GNE-317 |
≥98% | | 询价 |
| 42 | 1159824-67-5 | CZC24832 |
≥98% | | 询价 |
| 43 | 1246560-33-7 | VS-5584(SB-2343) |
≥98% | | 询价 |
| 44 | 925705-73-3 | TG100713 |
≥98% | | 询价 |
| 45 | 1173204-81-3 | PKI-402 |
≥98% | | 询价 |
| 46 | 900185-01-5 | PIK-293(IC-87114) |
≥98% | | 询价 |
| 47 | 1218777-13-9 | CAY10505 |
≥98% | | 询价 |
| 48 | 1007207-67-1 | CH5132799 |
≥98% | | 询价 |
| 49 | 371942-69-7 | YM201636 |
≥98% | | 询价 |
| 50 | 1032568-63-0 | Copanlisib(BAY80-6946 Aliqopa) |
≥98% | | 询价 |
| 51 | 1207456-01-6 | BMN673(Talazoparib) |
| 2mg, 5mg, 10mg, 50mg, 100mg | 询价 |
| 52 | 1372540-25-4 | GSK2636771 |
≥98% | | 询价 |
| 53 | 648449-76-7 | AS-604850 |
≥98% | | 询价 |
| 54 | 129-56-6 | SP600125 |
| 10mg, 25mg, 50mg, 100mg | 询价 |
| 55 | 900185-02-6 | PIK-294 |
≥98% | | 询价 |
| 56 | 1339928-25-4 | Fimepinostat(CUDC907) |
≥98% | | 询价 |
| 57 | 1245537-68-1 | BGT226(NVP-BGT226) |
≥98% | | 询价 |
| 58 | 900515-16-4 | AS-252424 |
≥98% | | 询价 |
| 59 | 677297-51-7 | TG100-115 |
≥98% | | 询价 |
| 60 | 941685-37-6 | S-Ruxolitinib(INCB-018424) |
≥98% | | 询价 |
m.cnreagent.com